NEXIEN BIOPHARMA, INC. Fair Value, Net Asset (Liability)
NEXIEN BIOPHARMA, INC. had Fair Value, Net Asset (Liability) of $0 as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes
us-gaap:FairValueNetAssetLiability · last filed 2025-05-14
- 2025-03-31: Fair Value, Net Asset (Liability) $0.00.
- 2024-12-31: Fair Value, Net Asset (Liability) $0.00.
- 2024-06-30: Fair Value, Net Asset (Liability) $0.00.
| Period end | Fair Value, Net Asset (Liability) |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-14 |
| 2024-06-30 | $0.00 10-Q · filed 2025-05-14 |